Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.10
+0.48 (3.28%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of 17.5, with a low estimate of 17 and a high estimate of 18. The average target predicts an increase of 15.89% from the current stock price of 15.10.
Analyst Consensus: Buy
* Price targets were last updated on Apr 30, 2026.
Analyst Ratings
The average analyst rating for Anika Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Sep '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $17 | Buy | Maintains | $17 | +12.58% | Apr 30, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +19.21% | Feb 27, 2026 |
Financial Forecast
Revenue This Year
118.61M
from 112.82M
Increased by 5.14%
Revenue Next Year
126.58M
from 118.61M
Increased by 6.72%
EPS This Year
0.41
from 0.11
Increased by 272.73%
EPS Next Year
0.46
from 0.41
Increased by 12.20%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 118.7M | 127.6M | |
| Avg | 118.6M | 126.6M | |
| Low | 118.5M | 125.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.2% | 7.6% | |
| Avg | 5.1% | 6.7% | |
| Low | 5.0% | 5.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.41 | 0.46 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 272.7% | 12.2% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.